New world simian foamy virus infections in vivo and in vitro

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 982-991

  Stenbak, Carolyn R ^a   Craig, Karen L ^b   Ivanov, Sergei B ^b   Wang, Xiaoxing ^b   Soliven, Khanh C ^b   Jackson, Dana L ^b   Gutierrez, Gustavo A ^c   Engel, Gregory ^d   Jones Engel, Lisa ^e   Linial, Maxine L ^b  

^a SEATTLE UNIVERSITY   (United States)

^b USA   (United States)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^d Swedish/Cherry Hill Family Medicine Residency Faculty   (United States)

^e Washington National Primate Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEW WORLD SIMIAN FOAMY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN FOAMY VIRUS; SPIDER MONKEY; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL LINE; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MONKEY DISEASES; PLATYRRHINI; RETROVIRIDAE INFECTIONS; SIMIAN FOAMY VIRUS; ZOONOSES;

EID: 84891677263     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03154-13     Document Type: Article

References (55)

1. Meiering CD, Linial ML. 2001. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14:165-176. http://dx.doi.org/10.1128/CMR.14.1.165-176.2001.
2. Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong Me Lam L, Heneine W, Folks TM, Chapman LE. 2007. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res. Hum. Retroviruses 23:1330-1337. http://dx.doi.org/10.1089/aid.2007.0104.
3. Linial ML. 2007. Foamy viruses, p 2245-2263. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott Williams&Wilkins, Philadelphia, PA.
4. Murray SM, Picker LJ, Axthelm MK, Linial ML. 2006. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J. Virol. 80:663-670. http://dx.doi.org/10.1128/JVI.80.2.663-670.2006.
5. Murray SM, Picker LJ, Axthelm MK, Hudkins K, Alpers CE, Linial ML. 2008. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J. Virol. 82:5981-5985. http://dx.doi.org/10.1128/JVI.00367-08.
6. Jones-Engel L, Steinkraus KA, Murray SM, Engel GA, Grant R, Aggimarangsee N, Lee BPY-H, May C, Schillaci MA, Somgird C, Sutthipat T, Vojtech L, Zhao J-Y, Linial ML. 2007. Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, freeranging, Asian monkeys. J. Virol. 81:7330-7337. http://dx.doi.org/10.1128/JVI.00343-07.
7. Gessain A, Rua R, Betsem E, Turpin J, Mahieux R. 2013. HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, crosss-pecies transmission and molecular virology. Virology 435:187-199. http://dx.doi.org/10.1016/j.virol.2012.09.035.
8. Feeroz M, Soliven K, Small C, Engel G, Pacheco M, Yee J, Wang X, Hasan K, Oh G, Levine K, Alam S, Craig K, Jackson D, Lee E-G, Barry P, Lerche N, Escalante A, Matsen F, Linial M, Jones-Engel L. 2013. Population dynamics of rhesus macaques and associated foamy virus in Bangladesh. Emerg. Microbes Infect. 2:e29. http://dx.doi.org/10.1038/emi.2013.23.
9. Calattini S, Betsem EB, Froment A, Mauclere P, Tortevoye P, Schmitt C, Njouom R, Saib A, Gessain A. 2007. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg. Infect. Dis. 13:1314-1320. http://dx.doi.org/10.3201/eid1309.061162.
10. Mouinga-Ondeme A, Caron M, Nkogh D, Telfer P, Marx P, Saib A, Leroy E, Gonzalez JP, Gessain A, Kazanji M. 2012. Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa. J. Virol. 86:1255-1260. http://dx.doi.org/10.1128/JVI.06016-11.
11. Betsem E, Rua R, Tortevoye P, Froment A, Gessain A. 2011. Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog. 7(10):e1002306. http://dx.doi.org/10.1037/journal.ppat.1002306.
12. Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, Lerche NW, Yee JL, Ely JJ, Boneva R, Chapman LE, Folks TM, Heneine W. 2004. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78:2780-2789. http://dx.doi.org/10.1128/JVI.78.6.2780-2789.2004.
13. Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM. 1998. Identification of a human population infected with simian foamy viruses. Nat. Med. 4:403-407.
14. Schweizer M, Falcone V, Gänge J, Turek R, Neumann-Haefelin D. 1997. Simian foamy virus isolated from an accidentally infected human individual. J. Virol. 71:4821-4824.
15. Sandstrom PA, Phan KO, Switzer WM, Fredeking T, Chapman L, Heneine W, Folks TM. 2000. Simian foamy virus infection among zoo keepers. Lancet 355:551-552. http://dx.doi.org/10.1016/S0140-6736(99)05292-7.
16. Brooks JI, Rud EW, Pilon RG, Smith JM, Switzer WM, Sandstrom PA. 2002. Cross-species retroviral transmission from macaques to human beings. Lancet 360:387-388. http://dx.doi.org/10.1016/S0140-6736(02)09597-1.
17. Huang F, Wang H, Jing S, Zeng W. 2012. Simian foamy virus prevalence in Macaca mulatta and zookeepers. AIDS Res. Hum. Retroviruses 28:591-593. http://dx.doi.org/10.1089/aid.2011.0305.
18. Hershkovitz P. 1977. Living New World monkeys (Platyrrhini). University of Chicago Press, Chicago, IL.
19. Muniz CP, Troncoso LL, Moreira MA, Soares EA, Pissinatti A, Bonvicino CR, Seuanez HN, Sharma B, Jia H, Shankar A, Switzer WM, Santos AF, Soares MA. 2013. Identification and characterization of highly divergent simian foamy viruses in a wide range of New World primates from Brazil. PLoS One 8(7):e67568. http://dx.doi.org/10.1371/journal.pone.0067568.
20. Engel GA, Jones-Engel L. 2012. Primates and primatologists: social contexts for interspecies pathogen transmission. Am. J. Primatol. 75:543-550. http://dx.doi.org/10.1002/ajp.20988.
21. Yu SF, Linial ML. 1993. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J. Virol. 67:6618-6624.
22. Aronoff R, Linial ML. 1991. Specificity of retroviral RNA packaging. J. Virol. 65:71-80.
23. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
24. Macpherson I, Stoker M. 1962. Polyoma transformation of hamster cell clones: an investigation of genetic factors affecting cell competence. Virology 16:147-151. http://dx.doi.org/10.1016/0042-6822(62)90290-8.
25. Kirchoff V, Wong S, St Jeor S, Pari GS. 2002. Generation of a life-expanded rhesus monkey fibroblast cell line for the growth of rhesus rhadinovirus (RRV). Arch. Virol. 147:321-333. http://dx.doi.org/10.1007/s705-002-8322-9.
26. Nelson-Rees WA, Owens RB, Arnstein P, Kniazeff AJ. 1976. Source, alterations, characteristics and use of a new dog cell line (Cf2Th). In Vitro 12:665-669. http://dx.doi.org/10.1007/BF02797468.
27. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. 1983. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809-1818.
28. Barranco SC, Townsend CM, Jr, Casartelli C, Macik BG, Burger NL, Boerwinkle WR, Gourley WK. 1983. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 43:1703-1709.
29. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:361-366.
30. Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ, Trujillo JM. 1976. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res. 36:467-475.
31. Cailleau R, Young R, Olivé M, Reeves WJ, Jr. 1974. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:661-674.
32. Herchenroder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA. 1994. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201:187-199. http://dx.doi.org/10.1006/viro.1994.1285.
33. Mergia A, Wu M. 1998. Characterization of provirus clones of simian foamy virus type 1. J. Virol. 72:817-822.
34. Lee E-G, Sinicrope A, Jackson DL, Yu SF, Linial ML. 2012. Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production. J. Virol. 86:5992-6001. http://dx.doi.org/10.1128/JVI.06979-11.
35. Baldwin DN, Linial ML. 1998. The roles of Pol and Env in the assembly pathway of human foamy virus. J. Virol. 72:3658-3665.
36. Schweizer M, Neumann-Haefelin D. 1995. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577-582. http://dx.doi.org/10.1006/viro.1995.1120.
37. Thümer L, Rethwilm A, Holmes EC, Bodem J. 2007. The complete nucleotide sequence of a New World simian foamy virus. Virology 369:191-197. http://dx.doi.org/10.1016/j.virol.2007.07.018.
38. Pacheco B, Finzi A, McGee-Estrada K, Sodroski J. 2010. Species-specific inhibition of foamy viruses from South American monkeys by New World monkey TRIM5α proteins. J. Virol. 84:4095-4099. http://dx.doi.org/10.1128/JVI.02631-09.
39. Engel GA, Small CT, Soliven K, Feeroz MM, Wang X, Hasan MK, Oh G, Alam SMR, Craig KL, Jackson DL, Matsen FA, IV, Linial ML, Jones-Engel L. 2013. Zoonotic simian foamy virus in Bangladesh reflects diverse patterns of transmission and co-infection. Emerg. Microbes Infect. 2:e58. http://dx.doi.org/10.1038/emi.2013.60.
40. Bodem J. 2011. Regulation of foamy viral transcription and RNA export, p 1-31. In Maramorosch K, Shatkin AJ, Murphy FA (ed), Advances in virus research, vol 78. Academic Press, London, England.
41. Khan AS, Kumar D. 2006. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 46:1352-1359. http://dx.doi.org/10.1111/j.1537-2995.2006.00862.x.
42. Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, Hanenberg H, Ohkura S, Stoye JP. 2008. Restriction of foamy viruses by primate Trim5α. J. Virol. 82:5429-5439. http://dx.doi.org/10.1128/JVI.02462-07.
43. Holmes RK, Malim MH, Bishop KN. 2007. APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32:118-128. http://dx.doi.org/10.1016/j.tibs.2007.01.004.
44. Perkovic M, Schmidt S, Marino D, Russell RA, Stauch B, Hofmann H, Kopietz F, Kloke BP, Zielonka J, Strover H, Hermle J, Lindemann D, Pathak VK, Schneider G, Lochelt M, Cichutek K, Munk C. 2009. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein Bet. J. Biol. Chem. 284:5819-5826. http://dx.doi.org/10.1074/jbc.M808853200.
45. Russell RA, Wiegand HL, Moore MD, Schafer A, McClure MO, Cullen BR. 2005. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79:8724-8731. http://dx.doi.org/10.1128/JVI.79.14.8724-8731.2005.
46. Lochelt M, Romen F, Bastone P, Muckenfuss H, Kirchner N, Kim YB, Truyen U, Rosler U, Battenberg M, Saib A, Flory E, Cichutek K, Munk C. 2005. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U. S. A. 102:7982-7987. http://dx.doi.org/10.1073/pnas.0501445102.
47. Delebecque F, Suspene R, Calattini S, Casartelli N, Saib A, Froment A, Wain-Hobson S, Gessain A, Vartanian JP, Schwartz O. 2006. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80:605-614. http://dx.doi.org/10.1128/JVI.80.2.605-614.2006.
48. Vasudevan A, Perkovi-ç Bulliard MY, Cichutek K, Trono D, haussinger d, Munk C. 2013. Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G. J. Virol. 87:9030-9040. http://dx.doi.org/10.1128/JVI.03385-12.
49. Rua R, Betsem E, Calattini S, Saib A, Gessain A. 2012. Genetic characterization of simian foamy viruses infecting humans. J. Virol. 86:13350-13359. http://dx.doi.org/10.1128/JVI.01715-12.
50. Switzer WM, Parekh B, Shanmugam V, Bhullar V, Phillips S, Ely JJ, Heneine W. 2005. The epidemiology of simian immunodeficiency virus infection in a large number of wild- and captive-born chimpanzees: evidence for a recent introduction following chimpanzee divergence. AIDS Res. Hum. Retroviruses 21:335-342. http://dx.doi.org/10.1089/aid.2005.21.335.
51. Han GZ, Worobey M. 2012. An endogenous foamy virus in the aye-aye (Daubentonia madagascariensis). J. Virol. 86:7696-7698. http://dx.doi.org/10.1128/JVI.00650-12.
52. Butera ST, Brown J, Callahan ME, Owen SM, Matthews AL, Weigner DD, Chapman LE, Sandstrom PA. 2000. Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses. J. Am. Vet. Med. Assoc. 217:1475-1479.
53. Plochmann K, Horn A, Gschmack E, Armbruster N, Krieg J, Wiktorowicz T, Weber C, Stirnnagel K, Lindemann D, Rethwilm A, Scheller C. 2012. Heparan sulfate is an attachment factor for foamy virus entry. J. Virol. 86:10028-10035. http://dx.doi.org/10.1128/JVI.00051-12.
54. Soliven K, Wang X, Small CT, Feeroz MM, Lee E-G, Craig KL, Hasan K, Engel GA, Jones-Engel L, Matsen FA, IV, Linial ML. 2013. Simian foamy virus infection of rhesus macaques in Bangladesh: relationship of latent proviruses and transcriptionally active viruses. J. Virol. 87:13628-13639. http://dx.doi.org/10.1128/JVI.01989-13.
55. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D. 1994. Genetic stability of foamy viruses: long-term study in an African green monkey population. J. Virol. 73:9256-9265.